ES2009140A6 - Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. - Google Patents

Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen.

Info

Publication number
ES2009140A6
ES2009140A6 ES8700289A ES8700289A ES2009140A6 ES 2009140 A6 ES2009140 A6 ES 2009140A6 ES 8700289 A ES8700289 A ES 8700289A ES 8700289 A ES8700289 A ES 8700289A ES 2009140 A6 ES2009140 A6 ES 2009140A6
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
human monoclonal
antibodies
production
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8700289A
Other languages
English (en)
Spanish (es)
Inventor
Howard V Raff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of ES2009140A6 publication Critical patent/ES2009140A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES8700289A 1986-02-07 1987-02-06 Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen. Expired ES2009140A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82800586A 1986-02-07 1986-02-07
US94449586A 1986-12-19 1986-12-19

Publications (1)

Publication Number Publication Date
ES2009140A6 true ES2009140A6 (es) 1989-09-01

Family

ID=27125154

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700289A Expired ES2009140A6 (es) 1986-02-07 1987-02-06 Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen.

Country Status (28)

Country Link
US (2) US5717071A (show.php)
JP (1) JP2645343B2 (show.php)
KR (1) KR870007697A (show.php)
CN (1) CN87102167A (show.php)
AT (1) AT398781B (show.php)
BE (1) BE1000967A5 (show.php)
CA (1) CA1339013C (show.php)
CH (1) CH672072A5 (show.php)
DE (1) DE3703711A1 (show.php)
DK (1) DK63187A (show.php)
ES (1) ES2009140A6 (show.php)
FI (1) FI94489C (show.php)
FR (1) FR2595946B1 (show.php)
GB (1) GB2186592B (show.php)
GR (1) GR870194B (show.php)
HK (1) HK21795A (show.php)
HU (1) HU203583B (show.php)
IE (1) IE59627B1 (show.php)
IL (1) IL81370A (show.php)
IT (1) IT1207589B (show.php)
LU (1) LU86761A1 (show.php)
MX (1) MX9203629A (show.php)
NL (1) NL8700286A (show.php)
NO (1) NO176924C (show.php)
NZ (2) NZ233920A (show.php)
OA (1) OA08477A (show.php)
PT (1) PT84258B (show.php)
SE (1) SE468747B (show.php)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
DE3925161A1 (de) * 1989-03-15 1990-09-27 Boehringer Mannheim Gmbh Monoklonale, gegen eca gerichtete antikoerper und ihre verwendung
WO1990013660A2 (en) * 1989-05-09 1990-11-15 Cetus Corporation Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
US6315999B1 (en) 1989-08-10 2001-11-13 Solvay, S.A. Pharmaceutical product for the treatment of sepsis
GB8918232D0 (en) * 1989-08-10 1989-09-20 Opal Stephen M Pharmaceutical product for the treatment of septic shock
US20080139789A1 (en) * 1990-10-22 2008-06-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated Broadly Reactive Opsonic Immunoglobulin for Treating a Pathogenic Coagulase-Negative Staphylococcus Infection
WO1993019373A1 (en) * 1992-03-19 1993-09-30 U.S. GOVERNMENT, as represented by THE SECRETARY O Broadly reactive opsonic antibodies that react with common staphylococcal antigens
EP0680337A4 (en) * 1993-01-12 1997-07-30 Anthony George Gristina METHODS AND COMPOSITIONS FOR DIRECT APPLICATION WITH HIGH CONCENTRATION OF ANTIBODIES, PRODUCING PASSIVE IMMUNITY.
US5510264A (en) * 1993-09-28 1996-04-23 Insight Biotech Inc. Antibodies which bind meningitis related homologous antigenic sequences
WO1999054357A1 (en) * 1998-04-14 1999-10-28 Chugai Research Institute For Molecular Medicine, Inc. Novel cytokine-like protein
KR101595234B1 (ko) * 2007-07-23 2016-02-26 사노피 파스퇴르 리미티드 면역원성 폴리펩타이드 및 단일클론 항체
SG174367A1 (en) * 2009-03-23 2011-10-28 Quark Pharmaceuticals Inc Compounds compositions and methods of treating cancer and fibrotic diseases
RU2589256C2 (ru) 2010-12-03 2016-07-10 Санофи Пастер Лимитид Композиции и способы для иммунизации против streptococcus pneumoniae
AU2016353073A1 (en) * 2015-11-10 2018-06-07 Visterra, Inc. Antibody molecule-drug conjugates that specifically binds to lipopolysaccharide and uses thereof
CA3049449A1 (en) 2017-01-18 2018-07-26 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
AU2021248643A1 (en) 2020-04-03 2022-10-27 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
AU567693B2 (en) * 1982-09-30 1987-12-03 University Of Rochester Human monoclonal antibodies against bacterial toxins
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
US4675287A (en) * 1984-07-26 1987-06-23 Scripps Clinic And Research Foundation Monoclonal antibody directed to human ganglioside GD2
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus

Also Published As

Publication number Publication date
HU203583B (en) 1991-08-28
SE8700467L (sv) 1987-08-08
CA1339013C (en) 1997-03-25
SE468747B (sv) 1993-03-15
KR870007697A (ko) 1987-09-21
IL81370A (en) 1991-06-30
GB8702689D0 (en) 1987-03-11
FI94489C (fi) 1995-09-25
AT398781B (de) 1995-01-25
FI870502A0 (fi) 1987-02-06
GR870194B (en) 1987-06-10
HUT46062A (en) 1988-09-28
US5717071A (en) 1998-02-10
CN87102167A (zh) 1988-02-03
BE1000967A5 (fr) 1989-05-30
DK63187D0 (da) 1987-02-06
NO870476L (no) 1987-08-10
CH672072A5 (show.php) 1989-10-31
IT1207589B (it) 1989-05-25
IE870320L (en) 1987-08-07
IT8719292A0 (it) 1987-02-06
NO176924C (no) 1995-06-21
FR2595946A1 (fr) 1987-09-25
LU86761A1 (fr) 1987-09-15
NZ219187A (en) 1990-12-21
MX9203629A (es) 1992-07-01
ATA26287A (de) 1994-06-15
SE8700467D0 (sv) 1987-02-06
GB2186592B (en) 1990-08-01
NO870476D0 (no) 1987-02-06
GB2186592A (en) 1987-08-19
HK21795A (en) 1995-02-24
DE3703711C2 (show.php) 1993-06-24
PT84258A (en) 1987-03-01
JP2645343B2 (ja) 1997-08-25
IE59627B1 (en) 1994-03-09
FI870502L (fi) 1987-08-08
FI94489B (fi) 1995-06-15
NO176924B (no) 1995-03-13
JPS62270535A (ja) 1987-11-24
PT84258B (pt) 1989-09-14
DK63187A (da) 1987-08-08
NZ233920A (en) 1990-12-21
FR2595946B1 (fr) 1991-10-04
NL8700286A (nl) 1987-09-01
IL81370A0 (en) 1987-08-31
US5837541A (en) 1998-11-17
OA08477A (fr) 1988-07-29
DE3703711A1 (de) 1987-09-24

Similar Documents

Publication Publication Date Title
ES2009140A6 (es) Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen.
DE69940371D1 (de) Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline
MX9710479A (es) Extracto de iridaceas y composiciones que la contienen.
DE3280150D1 (de) Mikroorganismen fuer den mikrobiellen abbau von schaedlichen organischen abfallstoffen in unschaedliche materialien.
DE3580054D1 (de) Chitinase produzierende bakterien.
DE69432351D1 (de) Verfahren zum sterilisieren von produkten
TR200102809T2 (tr) Bitki hastalıklarının kontrol edilmesi için bacillus pumilus soyu
DE69423781D1 (de) Rapamycin-derivate als immunosuppressoren
ES8405071A1 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
ATE441670T1 (de) Fraktionierung von getreide und daraus resultierende produkte
DK1292319T3 (da) Ekstrakter med anti-tumoraktivitet fra spermatofytplanter
BR8300177A (pt) Compostos,processo para sua preparacao,composicoes e processo para o combate ou inibicao de uma infestacao por microorganismos em plantas de cultura
EP0354491A3 (en) Nematicidal microorganisms, their isolation and their use as bionemacides
ATE231340T1 (de) Synergistische nematozide zusammensetzungen
BR8301032A (pt) Derivados de azolilpropano,processo para sua preparacao,composicoes e processo para o combate ou impedimento de uma infestacao de plantas de cultura por microorganismos e emprego
NO932381L (no) Halogenalkalifile mikroorganismer
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
SE7808133L (sv) Antipruritiska ektoparasiticider
Mironov Microorganisms growing in oil and oil products in western and central regions of the mediterranean sea
ATE269090T1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
ES472230A1 (es) Metodo para producir el antibiotico c-15003 p-o.
ES2113647T3 (es) Composicion.
FR2354314A1 (fr) Nouveaux antibiotiques appeles neoviridogriseines et leur procede de preparation
PT98578A (pt) Processo para a preparacao de enzimas tolerantes a alcalis e de composicoes que os contem
ES2093569B1 (es) Composicion de cultivo iniciador y su uso en la fabricacion de productos alimenticios.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401